Hepatitis C Antibody Positive, RNA Negative
Keith C. Summa, Haripriya Maddur – 2 August 2019
Erratum
2 August 2019
Early Liver Transplantation for Alcohol‐Associated Liver Disease: Need for Engagement and Education of All Stakeholders
John P. Rice, Brian P. Lee – 1 August 2019
Issue Information
1 August 2019
L‐Lactate–Based Improvement of Energetic Charge and Protection of Rat Liver
Bérengère Papegay, Vincent Nuyens, Véronique Kruys, Jean G. Boogaerts, Joseph Vamecq – 31 July 2019
Watching the Clock in Donation After Circulatory Death Liver Transplantation
Luis I. Ruffolo, Mark A. Levstik, Roberto Hernandez‐Alejandro – 31 July 2019
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy
Mattias Mandorfer, Karin Kozbial, Philipp Schwabl, David Chromy, Georg Semmler, Albert F. Stättermayer, Matthias Pinter, Virginia Hernández‐Gea, Monika Fritzer‐Szekeres, Petra Steindl‐Munda, Michael Trauner, Markus Peck‐Radosavljevic, Juan C. García‐Pagán, Peter Ferenci, Thomas Reiberger – 31 July 2019
Methyl‐Sensing Nuclear Receptor Liver Receptor Homolog‐1 Regulates Mitochondrial Function in Mouse Hepatocytes
Sungwoo Choi, Bingning Dong, Chih‐Chun Janet Lin, Mi Jeong Heo, Kang Ho Kim, Zhen Sun, Martin Wagner, Nagireddy Putluri, Jae Myoung Suh, Meng C. Wang, David D. Moore – 29 July 2019
Impact of Implementing a “FIB‐4 First” Strategy on a Pathway for Patients With NAFLD Referred From Primary Care
Tracy Davyduke, Puneeta Tandon, Mustafa Al‐Karaghouli, Juan G. Abraldes, Mang M. Ma – 29 July 2019 – Detection of advanced fibrosis in nonalcoholic fatty liver disease (NAFLD) is essential for stratifying patients according to the risk of liver‐related morbidity. Noninvasive methods such as vibration‐controlled transient elastography (VCTE) and Fibrosis‐4 index (FIB‐4) have been recommended to identify patients for further assessment. The aim of this study was to assess the potential impact of implementing a “FIB‐4 First” strategy to triage patients entering a NAFLD assessment pathway.